Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision on the page updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a new page revision has been published. This reflects a minor internal update to the page metadata rather than changes to the study's content.
    Difference
    0.0%
    Check dated 2026-08-08T10:00:04.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, replacing v3.6.3, indicating a small update to the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-07-25T06:21:29.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.2 to v3.6.3. This indicates a minor update to the page or its assets rather than a change to core content and user-facing features.
    Difference
    0.0%
    Check dated 2026-07-03T21:44:59.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.0 to v3.6.2, indicating a minor build update. This update does not modify the study details or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-06-26T20:16:49.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The page adds new navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and shows recruitment is closed. It also standardizes the Intervention/Treatment heading and updates the site revision from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T10:59:12.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The study record was updated to Terminated and now includes a new Strategic considerations section; the Petah Tikva location was broadened to include the Central District, and enrollment dates moved from estimated to actual, with a new revision timestamp.
    Difference
    0.7%
    Check dated 2026-06-05T08:29:45.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.